PreciseDM and HyperRevamp Form Strategic Alliance to Scale Innovative Diabetes Care Solution

PreciseDM, an innovative med-health company committed to improving diabetes care across the community, today announced a pivotal strategic partnership with HyperRevamp. This alliance is specifically engineered to accelerate the technological scaling, security, and market reach of PreciseDM's flagship product, diaForm, an essential insulin dosing tool for healthcare practitioners.

The collaboration comes at a crucial time, addressing the alarming statistic that 1 in 3 Americans are projected to have Type 2 diabetes by the year 2050.

The Urgent Need: Empowering Primary Care Providers

PreciseDM was founded with a clear vision: to combat the growing diabetes epidemic. The company recognized that the national shortage of endocrinologists and diabetic educators places a substantial burden on primary care providers (PCPs), who have become the mainstay for managing complex diabetes patients. This challenge is further complicated by the rise of conditions like COVID-induced diabetes.

In response, the company developed diaForm to empower these frontline practitioners.

The Practitioner’s Solution: The Precision of diaForm

The core of the PreciseDM platform, diaForm, is engineered as a decision-support tool to increase provider confidence and efficiency in managing insulin therapy.

What the diaForm App Does for Credentialed Practitioners:

The diaForm application acts as a quick, easy, and accurate dosing tool, specifically designed to be used by credentialed healthcare providers (Physicians, Physician Assistants, Nurse Practitioners, and Pharmacists). Its primary functions include:

• Individualized Insulin Dosing: Allowing providers to confidently and accurately determine the starting and maintenance insulin doses for patients new to insulin therapy.
• Time Savings: Streamlining the complex process of insulin titration, significantly reducing the time a provider spends calculating doses during a patient consultation.
• Confidence and Accuracy: Implementing evidence-based algorithms to ensure accurate dosing, improving diabetes care delivery and reducing provider hesitation regarding insulin initiation.

By providing quick, accurate support, diaForm helps PCPs confidently manage patients who might otherwise face delays in receiving necessary insulin treatment due to the shortage of specialists.

Scaling the Lifeline: The HyperRevamp Mandate

The partnership with HyperRevamp is a direct investment in the infrastructure required to scale this life-saving tool globally. HyperRevamp’s expertise in advanced platform scaling and robust security architecture will be leveraged to:

1. 1. Enhance Regulatory Security: Upgrade the data security framework to ensure the platform maintains the highest standards of medical data privacy and compliance globally.
2. 2. Optimize UX for Healthcare Workflow: Refine the mobile application’s interface to ensure zero friction, essential for busy practitioners who rely on speed and intuition during clinic hours.
3. 3. Prepare for Future Module Integration: Build a highly scalable foundation to seamlessly integrate the additional insulin dosing tools that PreciseDM plans to develop, furthering its mission to improve diabetes care delivery.

Wide Availability on iOS and Android

PreciseDM confirms its commitment to accessibility: the diaForm application is fully available for download and immediate use on both Apple (iOS) and Android mobile platforms, ensuring every credentialed provider has access, regardless of their device preference.

"The national shortage of endocrinologists made it imperative that we act decisively. diaForm is that action, providing the quick, easy, and accurate dosing support needed on the front lines," said Dr. Colleen Cook, PreciseDM’s CEO. "Partnering with HyperRevamp allows us to elevate our technology, ensuring that this critical tool is delivered with the necessary speed and security to improve diabetes care in our community, one member at a time."

Neeraj Kainth, HyperRevamp’s CEO, commented, “We are proud to lend our technical expertise to a product with such a profound social impact. Our focus is to provide the scalable, resilient architecture that allows diaForm to reach every PCP who needs it, transforming a tool into a robust, global solution in the fight against diabetes.”

About PreciseDM

PreciseDM is an innovative med-health company with the vision to improve the diabetes care of community members by developing smart, time-saving, and accurate digital tools for healthcare providers.

About HyperRevamp

HyperRevamp, specializing in scaling high-growth technology platforms, optimizing user experience, and delivering sustainable, high-performance digital solutions for market leaders.